Year archive

SynAct Pharma — 2026 filings

All 26 regulatory filings released by SynAct Pharma (SYNACT) in 2026, sourced directly from the official regulator.

26 Filings

2026 Period

2026 filings (26)

Filing	Released	Lang
Interim / Quarterly Report 2026 Interim / Quarterly Report Q1 2026	2026-05-27	Swedish
Interim / Quarterly Report 2026 Interim / Quarterly Report Q1 2026	2026-05-27	English
Kallelse till årsstämma i SynAct Pharma AB AGM Information	2026-05-08	English
Notice of annual general meeting in SynAct Pharma AB AGM Information	2026-05-07	English
SynAct Pharmas valberedning inför årsstämman 2026 Board/Management Information	2026-04-23	Swedish
SynAct Pharma’s Nomination Committee ahead of the 2026 Annual General Meeting Governance Information	2026-04-23	English
Annual Report 2025 Annual Report FY 2025	2026-04-15	Swedish
Major Shareholding Notification 2026 Major Shareholding Notification	2026-04-07	Swedish
Förändring av antalet aktier och röster i SynAct Pharma AB Share Issue/Capital Change	2026-03-31	Swedish
Change in number of shares and voting rights in Synact Pharma AB Share Issue/Capital Change	2026-03-31	English
Major Shareholding Notification 2026 Major Shareholding Notification	2026-03-27	Swedish
SynAct Pharma has carried out a directed issue of new shares of approximately 51.9 MSEK Capital/Financing Update	2026-03-02	English
SynAct Pharma har genomfört en riktad nyemission av aktier om cirka 51,9 MSEK Share Issue/Capital Change	2026-03-02	Swedish
SynAct Pharma offentliggör avsikt att genomföra en riktad nyemission om cirka 45 MSEK Capital/Financing Update	2026-03-02	Swedish
SynAct Pharma announces intention to carry out a directed issue of approximately 45 MSEK Capital/Financing Update	2026-03-02	English
SynAct Pharma appoints Ann Kristin Led as Chief Financial Officer Board/Management Information	2026-02-24	English
SynAct Pharma utser Ann Kristin Led till CFO Board/Management Information	2026-02-24	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report Q4 2025	2026-02-18	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report Q4 2025	2026-02-18	English
Återköp av aktier i Synact Pharma AB Transaction in Own Shares	2026-02-17	Swedish
Repurchase of shares in Synact Pharma AB Transaction in Own Shares	2026-02-17	English
Major Shareholding Notification 2026 Major Shareholding Notification	2026-01-28	Swedish
SynAct Pharmas utser Malin Wikstrand till tillförordnad CFO Board/Management Information	2026-01-19	Swedish
SynAct Pharma appoints Malin Wikstrand as interim CFO Board/Management Information	2026-01-19	English
Styrelsen för SynAct Pharma AB (publ) har beslutat om återköp av egna aktier Transaction in Own Shares	2026-01-09	Swedish
The Board of Directors of SynAct Pharma AB (publ) has resolved on the repurchase of own shares Transaction in Own Shares	2026-01-09	English